Reporte de caso
Medwave 2021;21(10):e8493 doi: 10.5867/medwave.2021.10.8493
Istmectomía para cáncer diferenciado de tiroides localizado en el istmo: reporte de dos casos y revisión de la literatura
Isthmusectomy for well-differentiated thyroid carcinoma located to the isthmus: A report of two cases and review of the literature
Roberto Ignacio Olmos Borzone, Jorge Andrés López Ruiz-Esquide, Francisco Domínguez Covarrubias, José Miguel Domínguez Ruiz-Tagle
Referencias | Descargar PDF |
Para Descargar PDF debe Abrir sesión.
Imprimir | A(+) A(-) | Lectura fácil

Palabras clave: Thyroid Neoplasms, Thyroid Cancer, Papillary, Thyroidectomy

Resumen

El cáncer papilar de tiroides es la neoplasia endocrina más frecuente, y debido a su pronóstico favorable, la extensión de la cirugía ha sido materia de debate. Aproximadamente el 10% de ellos están localizados en el istmo tiroideo, sin un manejo específico según las guías actuales. En las últimas décadas se ha propuesto la istmectomía como alternativa de manejo en el cáncer papilar de tiroides ubicado en el istmo. Presentamos los casos de dos pacientes con cáncer papilar de tiroides ístmico solitario, sin extensión extratiroídea macroscópica clínica ni compromiso ganglionar clínico ni radiológico, que fueron tratados con istmectomía sin disección ganglionar profiláctica. Ninguno tuvo complicaciones postoperatorias. Ambos fueron de riesgo de recurrencia intermedio debido a variantes histológicas agresivas. Ninguno tuvo recurrencia durante el seguimiento. Nuestro objetivo es mostrar que la istmectomía parece ser una alternativa quirúrgica efectiva y segura en pacientes adecuadamente seleccionados.


 

Solo está disponible la version en ingles de este artículo.

 

Papillary thyroid cancer is the most common endocrine malignancy, and due to its favorable prognosis, the extent of surgery has been a matter of debate. About 10% of these tumors are located in the thyroid isthmus, with no specific management in current guidelines. In the last decades, isthmusectomy has been proposed as a therapeutic option for isthmic papillary thyroid carcinoma, although there is no consensus on its management. We present two cases of patients from our institution with solitary isthmic papillary thyroid carcinoma without clinical macroscopic extrathyroidal extension or clinical-radiological lymph node involvement who were treated with isthmusectomy without prophylactic lymph node dissection. Neither of them had any postoperative complications. Both had an intermediate risk of recurrence due to aggressive variants. None of them had signs of recurrence during follow-up. We intend to show that isthmusectomy seems to be an effective and safe surgical alternative in selected patients through these cases.

Autores: Roberto Ignacio Olmos Borzone[1,4], Jorge Andrés López Ruiz-Esquide[2], Francisco Domínguez Covarrubias[3], José Miguel Domínguez Ruiz-Tagle[1,4]

Filiación:
[1] Departamento de Endocrinología, Facultad de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile
[2] Departamento de Medicina Interna, Facultad de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile
[3] Departamento de Cirugía Oncológica; Facultad de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile
[4] Centro Traslacional de Endocrinología UC, Facultad de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile

E-mail: jdomingu@uc.cl

Citación: Olmos Borzone RI, López Ruiz-Esquide JA, Domínguez Covarrubias F, Domínguez Ruiz-Tagle JM. Isthmusectomy for well-differentiated thyroid carcinoma located to the isthmus: A report of two cases and review of the literature. Medwave 2021;21(10):e8493 doi: 10.5867/medwave.2021.10.8493

Fecha de envío: 4/4/2021

Fecha de aceptación: 17/10/2021

Fecha de publicación: 29/11/2021

Origen: No solicitado

Tipo de revisión: Con revisión externa por tres pares revisores, a doble ciego en primera ronda

Comentarios (0)

Nos complace que usted tenga interés en comentar uno de nuestros artículos. Su comentario será publicado inmediatamente. No obstante, Medwave se reserva el derecho a eliminarlo posteriormente si la dirección editorial considera que su comentario es: ofensivo en algún sentido, irrelevante, trivial, contiene errores de lenguaje, contiene arengas políticas, obedece a fines comerciales, contiene datos de alguna persona en particular, o sugiere cambios en el manejo de pacientes que no hayan sido publicados previamente en alguna revista con revisión por pares.

Aún no hay comentarios en este artículo.


Para comentar debe iniciar sesión

Medwave publica las vistas HTML y descargas PDF por artículo, junto con otras métricas de redes sociales.

Se puede producir un retraso de 48 horas en la actualización de las estadísticas.

  1. Kitahara CM, Sosa JA. The changing incidence of thyroid cancer. Nat Rev Endocrinol. 2016 Nov;12(11):646-653. | CrossRef | PubMed |
  2. Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, et al. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid. 2016 Jan;26(1):1-133. | CrossRef | PubMed |
  3. Nixon IJ, Ganly I, Patel S, Palmer FL, Whitcher MM, Tuttle RM, et al. The impact of microscopic extrathyroid extension on outcome in patients with clinical T1 and T2 well-differentiated thyroid cancer. Surgery. 2011 Dec;150(6):1242-9. | CrossRef | PubMed |
  4. Vaisman F, Momesso D, Bulzico DA, Pessoa CH, da Cruz MD, Dias F, et al. Thyroid Lobectomy Is Associated with Excellent Clinical Outcomes in Properly Selected Differentiated Thyroid Cancer Patients with Primary Tumors Greater Than 1 cm. J Thyroid Res. 2013;2013:398194. | CrossRef | PubMed |
  5. Song E, Han M, Oh HS, Kim WW, Jeon MJ, Lee YM, et al. Lobectomy Is Feasible for 1-4 cm Papillary Thyroid Carcinomas: A 10-Year Propensity Score Matched-Pair Analysis on Recurrence. Thyroid. 2019 Jan;29(1):64-70. | CrossRef | PubMed |
  6. Olmos R, López J, Donoso F, Ruiz-Esquide M, Zegers T, Lustig N, et al. Manejo de nódulos tiroideos y cáncer de tiroides con lobectomía: experiencia de un equipo multidisciplinario. Rev Chil Endocrinol y Diabetes. 2020;13(3):118–24. | Link |
  7. Sugenoya A, Shingu K, Kobayashi S, Masuda H, Takahashi S, Shimizu T, et al. Surgical strategies for differentiated carcinoma of the thyroid isthmus. Head Neck. 1993 Mar-Apr;15(2):158-60. | CrossRef | PubMed |
  8. Nixon IJ, Palmer FL, Whitcher MM, Shaha AR, Shah JP, Patel SG, et al. Thyroid isthmusectomy for well-differentiated thyroid cancer. Ann Surg Oncol. 2011 Mar;18(3):767-70. | CrossRef | PubMed |
  9. Lee YS, Jeong JJ, Nam KH, Chung WY, Chang HS, Park CS. Papillary carcinoma located in the thyroid isthmus. World J Surg. 2010 Jan;34(1):36-9. | CrossRef | PubMed |
  10. Tala H, Díaz R, Domínguez JM, Pineda P, Olmos R, Munizaga F, et al. Protocolo Clínico Cáncer Diferenciado de Tiroides Programa de Cáncer del Adulto 2020. Sociedad Chilena de Endocrinología y Diabetes. 2020. | Link |
  11. Skilbeck C, Leslie A, Simo R. Thyroid isthmusectomy: a critical appraisal. J Laryngol Otol. 2007 Oct;121(10):986-9. | CrossRef | PubMed |
  12. Huang H, Liu S-Y, Ni S, Zhang Z-M, Wang X-L, Xu Z-G. Treatment Outcome of Papillary Carcinoma Confined to the Thyroid Isthmus. J Cancer Ther. 2016 Nov;07(12):963–9. | CrossRef |
  13. Tuttle RM, Zhang L, Shaha A. A clinical framework to facilitate selection of patients with differentiated thyroid cancer for active surveillance or less aggressive initial surgical management. Expert Rev Endocrinol Metab. 2018 Mar;13(2):77-85. | CrossRef | PubMed |
  14. Park H, Harries V, McGill MR, Ganly I, Shah JP. Isthmusectomy in selected patients with well-differentiated thyroid carcinoma. Head Neck. 2020 Jan;42(1):43-49. | CrossRef | PubMed |
  15. Seo HW, Song CM, Ji YB, Jeong JH, Koo HR, Tae K. Surgical Outcomes and Efficacy of Isthmusectomy in Single Isthmic Papillary Thyroid Carcinoma: A Preliminary Retrospective Study. J Invest Surg. 2021 Oct;34(10):1129-1134. | CrossRef | PubMed |
  16. Gui Z, Wang Z, Xiang J, Sun W, He L, Dong W, et al. Comparison of Outcomes Following Thyroid Isthmusectomy, Unilateral Thyroid Lobectomy, and Total Thyroidectomy in Patients with Papillary Thyroid Microcarcinoma of the Thyroid Isthmus: A Retrospective Study at a Single Center. Med Sci Monit. 2020 Dec 22;26:e927407. | CrossRef | PubMed |
  17. Gulcelik MA, Dogan L, Akgul GG, Güven EH, Ersöz Gulcelik N. Completion Thyroidectomy: Safer than Thought. Oncol Res Treat. 2018;41(6):386-390. | CrossRef | PubMed |
  18. Tessler FN, Middleton WD, Grant EG, Hoang JK, Berland LL, Teefey SA,et al. ACR Thyroid Imaging, Reporting and Data System (TI-RADS): White Paper of the ACR TI-RADS Committee. J Am Coll Radiol. 2017 May;14(5):587-595. | CrossRef | PubMed |
  19. Karatzas T, Charitoudis G, Vasileiadis D, Kapetanakis S, Vasileiadis I. Surgical treatment for dominant malignant nodules of the isthmus of the thyroid gland: A case control study. Int J Surg. 2015 Jun;18:64-8. | CrossRef | PubMed |
  20. Song CM, Lee DW, Ji YB, Jeong JH, Park JH, Tae K. Frequency and pattern of central lymph node metastasis in papillary carcinoma of the thyroid isthmus. Head Neck. 2016 Apr;38 Suppl 1:E412-6. | CrossRef | PubMed |
  21. Vasileiadis I, Boutzios G, Karalaki M, Misiakos E, Karatzas T. Papillary thyroid carcinoma of the isthmus: Total thyroidectomy or isthmusectomy? Am J Surg. 2018 Jul;216(1):135-139. | CrossRef | PubMed |
  22. Liu H, Li Y, Xiang J. Papillary Carcinoma of Thyroid Nodule if Located in Isthmus Is Associated with Greater Disease Progression: a Systematic Review and Meta-analysis. Indian J Surg. 2020 May 12;82(6):1212–8. | CrossRef |
  23. Wang J, Sun H, Gao L, Xie L, Cai X. Evaluation of thyroid isthmusectomy as a potential treatment for papillary thyroid carcinoma limited to the isthmus: A clinical study of 73 patients. Head Neck. 2016 Apr;38 Suppl 1:E1510-4. | CrossRef | PubMed |
  24. Randolph GW, Duh QY, Heller KS, LiVolsi VA, Mandel SJ, Steward DL, et al. The prognostic significance of nodal metastases from papillary thyroid carcinoma can be stratified based on the size and number of metastatic lymph nodes, as well as the presence of extranodal extension. Thyroid. 2012 Nov;22(11):1144-52. | CrossRef | PubMed |
  25. Viola D, Materazzi G, Valerio L, Molinaro E, Agate L, Faviana P, et al. Prophylactic central compartment lymph node dissection in papillary thyroid carcinoma: clinical implications derived from the first prospective randomized controlled single institution study. J Clin Endocrinol Metab. 2015 Apr;100(4):1316-24. | CrossRef | PubMed |
  26. Moon JH, Ryu CH, Cho SW, Choi JY, Chung EJ, Hah JH, et al. Effect of Initial Treatment Choice on 2-year Quality of Life in Patients with Low-risk Papillary Thyroid Microcarcinoma. J Clin Endocrinol Metab. 2021 Mar 8;106(3):724-735. | CrossRef | PubMed |
  27. Kuo EJ, Goffredo P, Sosa JA, Roman SA. Aggressive variants of papillary thyroid microcarcinoma are associated with extrathyroidal spread and lymph-node metastases: a population-level analysis. Thyroid. 2013 Oct;23(10):1305-11. | CrossRef | PubMed |
  28. Al-Qurayshi Z, Shama MA, Randolph GW, Kandil E. Minimal extrathyroidal extension does not affect survival of well-differentiated thyroid cancer. Endocr Relat Cancer. 2017 May;24(5):221-226. | CrossRef | PubMed |
  29. Diker-Cohen T, Hirsch D, Shimon I, Bachar G, Akirov A, Duskin-Bitan H, et al. Impact of Minimal Extra-Thyroid Extension in Differentiated Thyroid Cancer: Systematic Review and Meta-analysis. J Clin Endocrinol Metab. 2018 Mar 1. | CrossRef | PubMed |
  30. Ritter A, Mizrachi A, Bachar G, Vainer I, Shimon I, Hirsch D, et al. Detecting Recurrence Following Lobectomy for Thyroid Cancer: Role of Thyroglobulin and Thyroglobulin Antibodies. J Clin Endocrinol Metab. 2020 Jun 1;105(6):dgaa152. | CrossRef | PubMed |
  31. Park S, Jeon MJ, Oh HS, Lee YM, Sung TY, Han M,et al. Changes in Serum Thyroglobulin Levels After Lobectomy in Patients with Low-Risk Papillary Thyroid Cancer. Thyroid. 2018 Aug;28(8):997-1003. | CrossRef | PubMed |
Kitahara CM, Sosa JA. The changing incidence of thyroid cancer. Nat Rev Endocrinol. 2016 Nov;12(11):646-653. | CrossRef | PubMed |

Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, et al. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid. 2016 Jan;26(1):1-133. | CrossRef | PubMed |

Nixon IJ, Ganly I, Patel S, Palmer FL, Whitcher MM, Tuttle RM, et al. The impact of microscopic extrathyroid extension on outcome in patients with clinical T1 and T2 well-differentiated thyroid cancer. Surgery. 2011 Dec;150(6):1242-9. | CrossRef | PubMed |

Vaisman F, Momesso D, Bulzico DA, Pessoa CH, da Cruz MD, Dias F, et al. Thyroid Lobectomy Is Associated with Excellent Clinical Outcomes in Properly Selected Differentiated Thyroid Cancer Patients with Primary Tumors Greater Than 1 cm. J Thyroid Res. 2013;2013:398194. | CrossRef | PubMed |

Song E, Han M, Oh HS, Kim WW, Jeon MJ, Lee YM, et al. Lobectomy Is Feasible for 1-4 cm Papillary Thyroid Carcinomas: A 10-Year Propensity Score Matched-Pair Analysis on Recurrence. Thyroid. 2019 Jan;29(1):64-70. | CrossRef | PubMed |

Olmos R, López J, Donoso F, Ruiz-Esquide M, Zegers T, Lustig N, et al. Manejo de nódulos tiroideos y cáncer de tiroides con lobectomía: experiencia de un equipo multidisciplinario. Rev Chil Endocrinol y Diabetes. 2020;13(3):118–24. | Link |

Sugenoya A, Shingu K, Kobayashi S, Masuda H, Takahashi S, Shimizu T, et al. Surgical strategies for differentiated carcinoma of the thyroid isthmus. Head Neck. 1993 Mar-Apr;15(2):158-60. | CrossRef | PubMed |

Nixon IJ, Palmer FL, Whitcher MM, Shaha AR, Shah JP, Patel SG, et al. Thyroid isthmusectomy for well-differentiated thyroid cancer. Ann Surg Oncol. 2011 Mar;18(3):767-70. | CrossRef | PubMed |

Lee YS, Jeong JJ, Nam KH, Chung WY, Chang HS, Park CS. Papillary carcinoma located in the thyroid isthmus. World J Surg. 2010 Jan;34(1):36-9. | CrossRef | PubMed |

Tala H, Díaz R, Domínguez JM, Pineda P, Olmos R, Munizaga F, et al. Protocolo Clínico Cáncer Diferenciado de Tiroides Programa de Cáncer del Adulto 2020. Sociedad Chilena de Endocrinología y Diabetes. 2020. | Link |

Skilbeck C, Leslie A, Simo R. Thyroid isthmusectomy: a critical appraisal. J Laryngol Otol. 2007 Oct;121(10):986-9. | CrossRef | PubMed |

Huang H, Liu S-Y, Ni S, Zhang Z-M, Wang X-L, Xu Z-G. Treatment Outcome of Papillary Carcinoma Confined to the Thyroid Isthmus. J Cancer Ther. 2016 Nov;07(12):963–9. | CrossRef |

Tuttle RM, Zhang L, Shaha A. A clinical framework to facilitate selection of patients with differentiated thyroid cancer for active surveillance or less aggressive initial surgical management. Expert Rev Endocrinol Metab. 2018 Mar;13(2):77-85. | CrossRef | PubMed |

Park H, Harries V, McGill MR, Ganly I, Shah JP. Isthmusectomy in selected patients with well-differentiated thyroid carcinoma. Head Neck. 2020 Jan;42(1):43-49. | CrossRef | PubMed |

Seo HW, Song CM, Ji YB, Jeong JH, Koo HR, Tae K. Surgical Outcomes and Efficacy of Isthmusectomy in Single Isthmic Papillary Thyroid Carcinoma: A Preliminary Retrospective Study. J Invest Surg. 2021 Oct;34(10):1129-1134. | CrossRef | PubMed |

Gui Z, Wang Z, Xiang J, Sun W, He L, Dong W, et al. Comparison of Outcomes Following Thyroid Isthmusectomy, Unilateral Thyroid Lobectomy, and Total Thyroidectomy in Patients with Papillary Thyroid Microcarcinoma of the Thyroid Isthmus: A Retrospective Study at a Single Center. Med Sci Monit. 2020 Dec 22;26:e927407. | CrossRef | PubMed |

Gulcelik MA, Dogan L, Akgul GG, Güven EH, Ersöz Gulcelik N. Completion Thyroidectomy: Safer than Thought. Oncol Res Treat. 2018;41(6):386-390. | CrossRef | PubMed |

Tessler FN, Middleton WD, Grant EG, Hoang JK, Berland LL, Teefey SA,et al. ACR Thyroid Imaging, Reporting and Data System (TI-RADS): White Paper of the ACR TI-RADS Committee. J Am Coll Radiol. 2017 May;14(5):587-595. | CrossRef | PubMed |

Karatzas T, Charitoudis G, Vasileiadis D, Kapetanakis S, Vasileiadis I. Surgical treatment for dominant malignant nodules of the isthmus of the thyroid gland: A case control study. Int J Surg. 2015 Jun;18:64-8. | CrossRef | PubMed |

Song CM, Lee DW, Ji YB, Jeong JH, Park JH, Tae K. Frequency and pattern of central lymph node metastasis in papillary carcinoma of the thyroid isthmus. Head Neck. 2016 Apr;38 Suppl 1:E412-6. | CrossRef | PubMed |

Vasileiadis I, Boutzios G, Karalaki M, Misiakos E, Karatzas T. Papillary thyroid carcinoma of the isthmus: Total thyroidectomy or isthmusectomy? Am J Surg. 2018 Jul;216(1):135-139. | CrossRef | PubMed |

Liu H, Li Y, Xiang J. Papillary Carcinoma of Thyroid Nodule if Located in Isthmus Is Associated with Greater Disease Progression: a Systematic Review and Meta-analysis. Indian J Surg. 2020 May 12;82(6):1212–8. | CrossRef |

Wang J, Sun H, Gao L, Xie L, Cai X. Evaluation of thyroid isthmusectomy as a potential treatment for papillary thyroid carcinoma limited to the isthmus: A clinical study of 73 patients. Head Neck. 2016 Apr;38 Suppl 1:E1510-4. | CrossRef | PubMed |

Randolph GW, Duh QY, Heller KS, LiVolsi VA, Mandel SJ, Steward DL, et al. The prognostic significance of nodal metastases from papillary thyroid carcinoma can be stratified based on the size and number of metastatic lymph nodes, as well as the presence of extranodal extension. Thyroid. 2012 Nov;22(11):1144-52. | CrossRef | PubMed |

Viola D, Materazzi G, Valerio L, Molinaro E, Agate L, Faviana P, et al. Prophylactic central compartment lymph node dissection in papillary thyroid carcinoma: clinical implications derived from the first prospective randomized controlled single institution study. J Clin Endocrinol Metab. 2015 Apr;100(4):1316-24. | CrossRef | PubMed |

Moon JH, Ryu CH, Cho SW, Choi JY, Chung EJ, Hah JH, et al. Effect of Initial Treatment Choice on 2-year Quality of Life in Patients with Low-risk Papillary Thyroid Microcarcinoma. J Clin Endocrinol Metab. 2021 Mar 8;106(3):724-735. | CrossRef | PubMed |

Kuo EJ, Goffredo P, Sosa JA, Roman SA. Aggressive variants of papillary thyroid microcarcinoma are associated with extrathyroidal spread and lymph-node metastases: a population-level analysis. Thyroid. 2013 Oct;23(10):1305-11. | CrossRef | PubMed |

Al-Qurayshi Z, Shama MA, Randolph GW, Kandil E. Minimal extrathyroidal extension does not affect survival of well-differentiated thyroid cancer. Endocr Relat Cancer. 2017 May;24(5):221-226. | CrossRef | PubMed |

Diker-Cohen T, Hirsch D, Shimon I, Bachar G, Akirov A, Duskin-Bitan H, et al. Impact of Minimal Extra-Thyroid Extension in Differentiated Thyroid Cancer: Systematic Review and Meta-analysis. J Clin Endocrinol Metab. 2018 Mar 1. | CrossRef | PubMed |

Ritter A, Mizrachi A, Bachar G, Vainer I, Shimon I, Hirsch D, et al. Detecting Recurrence Following Lobectomy for Thyroid Cancer: Role of Thyroglobulin and Thyroglobulin Antibodies. J Clin Endocrinol Metab. 2020 Jun 1;105(6):dgaa152. | CrossRef | PubMed |

Park S, Jeon MJ, Oh HS, Lee YM, Sung TY, Han M,et al. Changes in Serum Thyroglobulin Levels After Lobectomy in Patients with Low-Risk Papillary Thyroid Cancer. Thyroid. 2018 Aug;28(8):997-1003. | CrossRef | PubMed |